Annals of Epidemiology
Volume 21, Issue 1 , Pages 67-69 , January 2011

Regarding “Meta-analysis and Causal Inference: A Case Study of Benzene and Non-Hodgkin Lymphoma”: An Incomplete Analysis

References 

  1. Weed DL. Meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma. Ann Epidemiol. 2010;20:347–355
  2. Steinmaus C, Smith AH, Jones RM, Smith MT. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med. 2008;65:371–378
  3. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4:218–228
  4. Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control. 1999;10:453–465
  5. Miller MD, Marty MA, Broadwin R, Johnson KC, Salmon AG, Winder B, et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med. 2007;44:93–106
  6. Weed DL. Meta-analysis under the microscope. J Natl Cancer Inst. 1997;89:904–905
  7. Chak E, Rutherford GW, Steinmaus C. The role of breast-feeding in the prevention of Helicobacter pylori infection: a systematic review. Clin Infect Dis. 2009;48:430–437
  8. Juni P, Altman D, Egger M. Assessing the quality of randomised controlled trials. In:  Egger M,  Davey Smith G,  Altman D editor. Systemic reviews in health care: Meta-analysis in context. London: BMJ Publishing Group; 2001;p. 100–101
  9. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev. 2004;13:771778
  10. Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res. 2009;681:150–168
  11. Steinmaus CM, Nunez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol. 2000;151:693–702
  12. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA. 2000;284:72–78
  13. Guha N, Merletti F, Steenland NK, Altieri A, Cogliano V, Straif K. Lung cancer risk in painters: a meta-analysis. Environ Health Perspect. 2010;118:303–312
  14. Greenland S. Meta-analysis. In:  Rothman K,  Greenland S editor. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Raven; 1998;p. 643–673
  15. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279:1566–1570
  16. Weed DL. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related. Int J Epidemiol. 2000;29:387–390
  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  18. Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine–National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89:1065–1071
  19. Rothman K, Greenland S. Causation and causal inference. In:  Rothman K,  Greenland S editor. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Raven; 1998;p. 7–28
  20. Garcia-Closas M, Lubin JH. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol. 1999;149:689–692
  21. Smith MT, Jones RM, Smith AH. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:385–391
  22. Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma–a review. Acta Oncol. 2006;45:258–271
  23. Grulich AE, Vajdic CM. The epidemiology of non–Hodgkin lymphoma. Pathology. 2005;37:409–419
  24. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1–12
  25. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol. 2000;12:383–394
  26. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin’s lymphoma. Oncogene. 2004;23:6524–6534
  27. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18(Suppl. 1):i3–i8
  28. Swerdlow AJ. Epidemiology of Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl. 1):S3–12
  29. CONCAWE. CONCAWE Membership, 2003. Available at: http://www.concawe.be/Content/Default.asp?PageID=9. Accessed May 5, 2010
  30. Michaels D. Regarding “Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project”: mercenary epidemiology–data reanalysis and reinterpretation for sponsors with financial interest in the outcome. Ann Epidemiol. 2006;16:583–585author reply 586

PII: S1047-2797(10)00153-5

doi: 10.1016/j.annepidem.2010.06.004

Annals of Epidemiology
Volume 21, Issue 1 , Pages 67-69 , January 2011

Article Tools